Intra-Cellular Therapies Inc (NASDAQ:ITCI)

45.35
Delayed Data
As of Sep 28
 +0.77 / +1.73%
Today’s Change
34.43
Today|||52-Week Range
66.00
-13.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues91.4K330.7K245.8K0.00
 
 
 
 
Depreciation And Amortization139.6K196.9K213.9K368.7K
 
 
 
 
 
 
Operating ExpensesGross Income-------368.7K
 
 
General Expenses105.8M118.4M102.9M161.9M
 
 
 
 
 
Research And Development87.7M93.8M79.4M132.2M
 
 
 
 
 
Total Operating Expenses105.9M118.6M103.1M162.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-105.8M-118.3M-102.8M-162.3M
 
 
 
 
 
Interest Expense On Debt0.0036.8K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-104.8M-115.4M-98.8M-155.1M
 
 
 
 
 
Income Taxes-1.6K-1.1M-1.1M-1.6K
 
 
 
 
 
Net Income-104.8M-116.4M-97.8M-155.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.1M43.2M46.2M54.7M
 
 
 
 
 
Shares To Calculate EPS Diluted36.1M43.2M46.2M54.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.91-$2.69-$2.12-$2.84
 
 
 
 
 
EPS Diluted-$2.91-$2.69-$2.12-$2.84